Connection

GARABED EKNOYAN to Adult

This is a "connection" page, showing publications GARABED EKNOYAN has written about Adult.
Connection Strength

0.159
  1. Tubulointerstitial nephritis and cancer chemotherapy: update on a neglected clinical entity. Nephrol Dial Transplant. 2013 Oct; 28(10):2502-9.
    View in: PubMed
    Score: 0.024
  2. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol. 2006 Feb; 17(2):546-55.
    View in: PubMed
    Score: 0.014
  3. Clinical practice guidelines for chronic kidney disease in adults: Part II. Glomerular filtration rate, proteinuria, and other markers. Am Fam Physician. 2004 Sep 15; 70(6):1091-7.
    View in: PubMed
    Score: 0.013
  4. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002 Dec 19; 347(25):2010-9.
    View in: PubMed
    Score: 0.011
  5. Continuous quality improvement: DOQI becomes K/DOQI and is updated. National Kidney Foundation's Dialysis Outcomes Quality Initiative. Am J Kidney Dis. 2001 Jan; 37(1):179-194.
    View in: PubMed
    Score: 0.010
  6. Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. Am J Kidney Dis. 1999 May; 33(5):1004-10.
    View in: PubMed
    Score: 0.009
  7. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int. 2011 Nov; 80(10):1080-91.
    View in: PubMed
    Score: 0.005
  8. Chronic tubulo-interstitial nephritis: correlation between structural and functional findings. Kidney Int. 1990 Oct; 38(4):736-43.
    View in: PubMed
    Score: 0.005
  9. Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients. Kidney Int. 2010 Apr; 77(7):624-9.
    View in: PubMed
    Score: 0.005
  10. Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the Hemodialysis (HEMO) Study. Am J Kidney Dis. 2008 Sep; 52(3):531-40.
    View in: PubMed
    Score: 0.004
  11. Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients. Clin J Am Soc Nephrol. 2008 Jan; 3(1):69-77.
    View in: PubMed
    Score: 0.004
  12. Renal involvement in patients with thrombotic thrombocytopenic purpura. Am J Nephrol. 1986; 6(2):117-31.
    View in: PubMed
    Score: 0.004
  13. Renal complications of bacterial endocarditis. Am J Nephrol. 1985; 5(6):457-69.
    View in: PubMed
    Score: 0.003
  14. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003 Jan; 41(1):1-12.
    View in: PubMed
    Score: 0.003
  15. Seasonal variations in clinical and laboratory variables among chronic hemodialysis patients. J Am Soc Nephrol. 2002 Sep; 13(9):2345-52.
    View in: PubMed
    Score: 0.003
  16. Phosphate therapy in diabetic ketoacidosis. Arch Intern Med. 1982 Mar; 142(3):517-20.
    View in: PubMed
    Score: 0.003
  17. Renal papillary necrosis: an update. Medicine (Baltimore). 1982 Mar; 61(2):55-73.
    View in: PubMed
    Score: 0.003
  18. Biochemical abnormalities of platelets in renal failure. Evidence for decreased platelet serotonin, adenosine diphosphate and Mg-dependent adenosine triphosphatase. Am J Nephrol. 1981; 1(1):17-23.
    View in: PubMed
    Score: 0.002
  19. Nephrotic syndrome developing after bee stings. South Med J. 1981 Jan; 74(1):82-3.
    View in: PubMed
    Score: 0.002
  20. Acute renal failure associated with indomethacin administration. South Med J. 1980 May; 73(5):587-9.
    View in: PubMed
    Score: 0.002
  21. The effect of age on the character of immune complex disease: a comparison of the incidence and relative size of materials reactive with Clq in sera of patients with glomerulonephritis and cancer. Medicine (Baltimore). 1979 Jan; 58(1):65-79.
    View in: PubMed
    Score: 0.002
  22. Minocycline and doxycycline kinetics in chronic renal failure. Clin Pharmacol Ther. 1978 Aug; 24(2):233-9.
    View in: PubMed
    Score: 0.002
  23. Care for hypertensives in a neighborhood clinic and a hospital outpatient department: a comparison. J Ambul Care Manage. 1978 Apr; 1(2):41-51.
    View in: PubMed
    Score: 0.002
  24. Renal localization of antiglobulins in glomerulonephritis and after renal transplantation. Arthritis Rheum. 1977 May; 20(4):947-61.
    View in: PubMed
    Score: 0.002
  25. The kidney and infections. Contrib Nephrol. 1977; 7:272-89.
    View in: PubMed
    Score: 0.002
  26. Renal complications of drug addiction. Urology. 1976 Dec; 8(6):526-31.
    View in: PubMed
    Score: 0.002
  27. Soluble immune complexes in sera of patients with nephritis. Kidney Int. 1976 Sep; 10(3):256-63.
    View in: PubMed
    Score: 0.002
  28. Use of cardioactive drugs in acute myocardial infarction. Heart Lung. 1976 Jan-Feb; 5(1):44-61.
    View in: PubMed
    Score: 0.002
  29. Antiglobulins and glomerulonephritis. Classification of patients by the reactivity of their sera and renal tissue with aggregated and native human IgG. J Clin Invest. 1975 Aug; 56(2):427-37.
    View in: PubMed
    Score: 0.002
  30. Malignant hypertension. Recovery of kidney function after renal allograft failure. Arch Intern Med. 1975 Feb; 135(2):300-3.
    View in: PubMed
    Score: 0.002
  31. Renal involvement in drug abuse. Arch Intern Med. 1973 Dec; 132(6):801-6.
    View in: PubMed
    Score: 0.002
  32. Recovery from anuria due to malignant hypertension. JAMA. 1971 Feb 15; 215(7):1122-5.
    View in: PubMed
    Score: 0.001
  33. Combined ascitic-fluid and furosemide infusion in the management of ascites. N Engl J Med. 1970 Mar 26; 282(13):713-7.
    View in: PubMed
    Score: 0.001
  34. Salutary effects of modest fluid replacement in the treatment of adults with diabetic ketoacidosis. Use in patients without extreme volume deficit. JAMA. 1989 Oct 20; 262(15):2108-13.
    View in: PubMed
    Score: 0.001
  35. Determinants of plasma potassium levels in diabetic ketoacidosis. Medicine (Baltimore). 1986 May; 65(3):163-72.
    View in: PubMed
    Score: 0.001
  36. Plasma acid-base patterns in diabetic ketoacidosis. N Engl J Med. 1982 Dec 23; 307(26):1603-10.
    View in: PubMed
    Score: 0.001
  37. Effects of renal failure on leukotaxis. J Med. 1979; 10(4):267-78.
    View in: PubMed
    Score: 0.001
  38. Effect of plasma exchange on circulating immune complexes and antibody formation in patients treated with cyclophosphamide and prednisone. Am J Med. 1977 Nov; 63(5):674-82.
    View in: PubMed
    Score: 0.001
  39. Treatment of Goodpasture syndrome with cyclophosphamide, prednisone and plasma exchange transfusions. Clin Exp Immunol. 1976 Apr; 24(1):218-22.
    View in: PubMed
    Score: 0.000
  40. Indomethacin treatment of pericarditis in chronic hemodialysis patients. Arch Intern Med. 1975 Jun; 135(6):807-10.
    View in: PubMed
    Score: 0.000
  41. Mitigation of amphotericin B nephrotoxicity by mannitol. Br Med J. 1975 Mar 08; 1(5957):550-1.
    View in: PubMed
    Score: 0.000
  42. The morphogenesis of glomerular crescents in rapidly progressive glomerulonephritis. Kidney Int. 1974 Jan; 5(1):47-56.
    View in: PubMed
    Score: 0.000
  43. Adult polycystic kidney disease: studies of the defect in urine concentration. Kidney Int. 1972 Aug; 2(2):107-13.
    View in: PubMed
    Score: 0.000
  44. Effects of metolazone on renal function in normal man. J Pharmacol Exp Ther. 1972 Jan; 180(1):6-12.
    View in: PubMed
    Score: 0.000
  45. Hereditary nephritis in the Negro. Report of a kindred. Arch Intern Med. 1970 Mar; 125(3):451-8.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.